1993
DOI: 10.1016/s0022-3476(05)81551-3
|View full text |Cite
|
Sign up to set email alerts
|

Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

5
104
0
6

Year Published

1996
1996
2012
2012

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 311 publications
(115 citation statements)
references
References 20 publications
5
104
0
6
Order By: Relevance
“…44 The current experience with iNO therapy, however, suggests that there is no loss of drug effect even after prolonged treatment, 45,46 on the contrary, iNO concentrations can be reduced in the course of treatment without losing effectiveness. 46,47 In our study, iNOinduced neuroprotection could not be improved by intermittent application of the therapy, suggesting that-as evidenced by other groups-tachyphylaxy does not occur during NO inhalation therapy.…”
Section: Discussionsupporting
confidence: 41%
“…44 The current experience with iNO therapy, however, suggests that there is no loss of drug effect even after prolonged treatment, 45,46 on the contrary, iNO concentrations can be reduced in the course of treatment without losing effectiveness. 46,47 In our study, iNOinduced neuroprotection could not be improved by intermittent application of the therapy, suggesting that-as evidenced by other groups-tachyphylaxy does not occur during NO inhalation therapy.…”
Section: Discussionsupporting
confidence: 41%
“…There were no systemic side effects, and methemoglobin levels remained stable. Kinsella et al showed the same result with lesser amounts of 10 to 20 ppm in 7 term neonates (17) . The improvement was sustained with NO 6 ppm for 24 hours.…”
Section: Discussionmentioning
confidence: 68%
“…One of the more intriguing discoveries in recent years was that iNO, acting as a selective pulmonary vasodilator, could produce marked benefit in neonates with PPHN (117,118). The early reports used considerably higher concentrations than those generally used today.…”
Section: Cardiopulmonary Supportmentioning
confidence: 99%